28.04.2015 • NewsDede WillamsChattemSanofi

Moberg Buys OTC Brand Balmex From Sanofi

Sweden's Moberg Pharma has acquired US over-the-counter drugmaker Balmex from Chattem, the US consumer healthcare division of French pharmaceutical producer Sanofi, for $3.9 million in cash.

The acquisition sum is roughly in line with the more than $4 million annual sales of the OTC specialist, whose portfolio includes products used for diaper rash. The brand will be sold through Moberg's current OTC channel in the US, primarily in chain drugstores, as well as hypermarket chain Walmart and at specialty toy retailers.

"Adding Balmex to Moberg Pharma's US portfolio is a great fit, within our core area of topical dermatology," said Moberg CEO Peter Wolpert.

He said the company is "continuously evaluating opportunities to further leverage its US sales and marketing infrastructure," and this deal contributes immediately to sales and earnings as well as the long-term financial goal of delivering profitable growth and an EBITDA margin of 25% from 2016.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.